Skip to main content
. Author manuscript; available in PMC: 2016 Jan 9.
Published in final edited form as: Vaccine. 2014 Dec 2;33(3):417–421. doi: 10.1016/j.vaccine.2014.11.036

Table 3.

Mouse survival following primary and secondary toxin challenges

1° CHLa 2° CHL


Groupb Ricin LT Ricin
RiVax A - 0/5 -

B 5/5* - -

DNI A - 5/5* 0/5

B 0/4c - -

Dual A - 4/5 4/4*

B 5/5 - -

Vehicle A - 0/5 -

B 0/5 - -
a

CHL, challenge;

b

Each group of mice (left column) was arbitrarily divided into two subsets, A and B. The A subset received a primary challenge with LT, while the B subset (shaded) received a primary challenge with ricin. The DNI-immunized and the dual-immunized A subsets of animals that survived LT challenge received a secondary challenge with ricin;

c

A single mouse in this group of animals died of unknown causes prior to the animal’s second immunization.

*

, indicates statistical significance (p<0.05) based on the Mantel-Cox test.